Am. J. Respir. Crit. Care Med., Vol 155, No. 6, 06 1997, 1914-1920.
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations
E Kerem, N Rave-Harel, A Augarten, I Madgar, M Nissim-Rafinia, Y Yahav, R Goshen, L Bentur, J Rivlin, M Aviram, A Genem, O Chiba-Falek, MR Kraemer, A Simon, D Branski and B Kerem
Department of Pediatrics, Cystic Fibrosis Clinic, Shaare Zedek Medical Center, Jerusalem, Israel.
Some patients express various features of cystic fibrosis (CF) even though
essential characteristics of the disease might be absent. Such patients may
suffer from respiratory disease without pancreatic insufficiency and normal
sweat chloride levels. Others may present as male infertility because of
congenital bilateral aplasia of the vas deferens (CBAVD) with no other
signs of CF. The 5T allele, a DNA variant in a noncoding region of the
cystic fibrosis transmembrane conductance regulator (CFTR) gene that
reduces the level of the normal CFTR transcripts, was found in increased
frequency among male patients with CBAVD. The purpose of this study was to
investigate the possibility that the 5T allele is associated with
dysfunction of organs other than the male reproductive system, leading to
CF or atypical CF. Analysis of the 5T allele was performed on 148 subjects
(29 with CF, 61 with atypical CF, and 58 with CBAVD) carrying 232
chromosomes with unidentified CFTR mutations, and on 142 non-CF chromosomes
from healthy subjects of Ashkenazi origin. The frequency of the 5T allele
among chromosomes from patients of Jewish Ashkenazi origin with CF and
atypical CF (six of 33; 18%) was significantly higher than the frequency in
the normal Ashkenazi population (eight of 142; 6%; p = 0.03). Analysis of
the clinical presentation of the five patients with CF and the 12 patients
with atypical CF carrying the 5T allele indicated that most patients
suffered from respiratory disease presenting as asthma like symptoms, nasal
polyposis, chronic sinusitis, chronic bronchitis, or bronchiectasis. Six
patients had pancreatic insufficiency, two with meconium ileus. Sweat Cl-
levels ranged from normal to elevated. Of the six male patients with
respiratory disease who were old enough to be evaluated for fertility
status, five were fertile and one had pancreatic insufficiency. Among male
patients with CBAVD, 41% suffered from respiratory symptoms. Thus, the 5T
allele is a variant with partial penetrance causing disease with an extreme
variability of clinical presentation: from normal healthy fertile subjects
or male patients with CBAVD to those with atypical or typical clinical
phenotype of CF.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Yaakov, E. Kerem, Y. Yahav, J. Rivlin, H. Blau, L. Bentur, M. Aviram, E. Picard, T. Bdolah-Abram, and M. Wilschanski
Reproducibility of Nasal Potential Difference Measurements in Cystic Fibrosis
Chest,
October 1, 2007;
132(4):
1219 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pagani, C. Stuani, M. Tzetis, E. Kanavakis, A. Efthymiadou, S. Doudounakis, T. Casals, and F. E. Baralle
New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12
Hum. Mol. Genet.,
May 15, 2003;
12(10):
1111 - 1120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Lyczak, C. L. Cannon, and G. B. Pier
Lung Infections Associated with Cystic Fibrosis
Clin. Microbiol. Rev.,
April 1, 2002;
15(2):
194 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wilschanski, H. Famini, N. Strauss-Liviatan, J. Rivlin, H. Blau, H. Bibi, L. Bentur, Y. Yahav, H. Springer, M.R. Kramer, et al.
Nasal potential difference measurements in patients with atypical cystic fibrosis
Eur. Respir. J.,
June 1, 2001;
17(6):
1208 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Chest,
March 1, 2001;
119(3):
762 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Desmarquest, D. Feldmann, A. Tamalat, M. Boule, B. Fauroux, G. Tournier, and A. Clement
Genotype Analysis and Phenotypic Manifestations of Children With Intermediate Sweat Chloride Test Results
Chest,
December 1, 2000;
118(6):
1591 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. NOONE, C. A. PUE, Z. ZHOU, K. J. FRIEDMAN, E. L. WAKELING, M. GANESHANANTHAN, R. H. SIMON, L. M. SILVERMAN, and M. R. KNOWLES
Lung Disease Associated with the IVS8 5T Allele of the CFTR Gene
Am. J. Respir. Crit. Care Med.,
November 1, 2000;
162(5):
1919 - 1924.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. MASSIE, D. DU SART, K. FORSHAW, J. CARLIN, and S M FORREST
The relationship between neonatal immunoreactive trypsinogen, Delta F508, and IVS8-5T
J. Med. Genet.,
August 1, 2000;
37(8):
629 - 632.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Nissim-Rafinia, O. Chiba-Falek, G. Sharon, A. Boss, and B. Kerem
Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations
Hum. Mol. Genet.,
July 22, 2000;
9(12):
1771 - 1778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. WILSCHANSKI, C. FAMINI, H. BLAU, J. RIVLIN, A. AUGARTEN, A. AVITAL, B. KEREM, and E. KEREM
A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop Mutations
Am. J. Respir. Crit. Care Med.,
March 1, 2000;
161(3):
860 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Friedman and L. M. Silverman
Cystic Fibrosis Syndrome: A New Paradigm for Inherited Disorders and Implications for Molecular Diagnostics
Clin. Chem.,
July 1, 1999;
45(7):
929 - 931.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Chmiel, M. L. Drumm, M. W. Konstan, T. W. Ferkol, and C. M. Kercsmar
Pitfall in the Use of Genotype Analysis as the Sole Diagnostic Criterion for Cystic Fibrosis
Pediatrics,
April 1, 1999;
103(4):
823 - 826.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Bronsveld, J. Bijman, F. Mekus, M. Ballmann, H. J Veeze, and B. Tümmler
Clinical presentation of exclusive cystic fibrosis lung disease
Thorax,
March 1, 1999;
54(3):
278 - 281.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Lissens, K. Z. Mahmoud, E. El-Gindi, A. Abdel-Sattar, S. Seneca, A. Van Steirteghem, and I. Liebaers
Molecular analysis of the cystic fibrosis gene reveals a high frequency of the intron 8 splice variant 5T in Egyptian males with congenital bilateral absence of the vas deferens
Mol. Hum. Reprod.,
January 1, 1999;
5(1):
10 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. PILEWSKI and R. A. FRIZZELL
Role of CFTR in Airway Disease
Physiol Rev,
January 1, 1999;
79(1):
215 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wilschanski, J. Rivlin, S. Cohen, A. Augarten, H. Blau, M. Aviram, L. Bentur, C. Springer, Y. Vila, D. Branski, et al.
Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease
Pediatrics,
January 1, 1999;
103(1):
52 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Cohn, K. J. Friedman, P. G. Noone, M. R. Knowles, L. M. Silverman, and P. S. Jowell
Relation between Mutations of the Cystic Fibrosis Gene and Idiopathic Pancreatitis
N. Engl. J. Med.,
September 3, 1998;
339(10):
653 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 American Thoracic Society
|
|
|